(Q39482701)

12 September 2017

Homocysteine and ischaemic heart disease in the Caerphilly cohort (English)

1 reference

arteriosclerotic heart disease

12 September 2017

1 reference

Ubbink JB

1

1 reference

12 September 2017

Fehily AM

2

1 reference

12 September 2017

Pickering J

3

1 reference

12 September 2017

Elwood PC

4

1 reference

12 September 2017

Vermaak WJ

5

1 reference

12 September 2017

1 October 1998

1 reference

12 September 2017

1 reference

12 September 2017

140

1 reference

12 September 2017

2

1 reference

12 September 2017

349-356

1 reference

Homocysteinemia: association of a metabolic disorder with vascular disease and thrombosis

12 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900139-7

The prevalence of homocysteinemia and hypercholesterolemia in angiographically defined coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900139-7

Hyperhomocysteinemia: an independent risk factor for vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900139-7

A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900139-7

Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900139-7

Hyperhomocysteinemia in patients operated for lower extremity ischaemia below the age of 50--effect of smoking and extent of disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900139-7

Disordered methionine/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900139-7

Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900139-7

A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900139-7

The role of free radicals as mediators of endothelial cell injury in hyperhomocysteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900139-7

Homocysteine induces iron-catalyzed lipid peroxidation of low-density lipoprotein that is prevented by alpha-tocopherol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900139-7

Diet and incident ischaemic heart disease: the Caerphilly Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900139-7

Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900139-7

Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900139-7

Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900139-7

Plasma concentrations of homocysteine and other aminothiol compounds are related to food intake in healthy human subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900139-7

Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900139-7

Serum total homocysteine and coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900139-7

Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900139-7

Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900139-7

Human arterial endothelial cell detachment in vitro: its promotion by homocysteine and cysteine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900139-7

Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900139-7

Metabolism of sulfur-containing amino acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900139-7

Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900139-7

Vitamin requirements for the treatment of hyperhomocysteinemia in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900139-7

Effects of age, lipoproteins, and hemostatic parameters on the role of homocyst(e)inemia as a cardiovascular risk factor in men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900139-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0021-9150(98)00139-7

1 reference

12 September 2017

1 reference